Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Claimed Company
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more
plenty of opportunities in the company for a dedicated employee who are capable and full of ideas
What is the best part about your compensation package?
flexible working hours, comparable benefits in biotech
What do you like best about the leadership team?
vision, hands-on, determined, quick decisions
What are some of the best things about your team?
dedicated, learn quickly, collaborative style
What is most positive about the culture and environment at your company?
innovative thinking, making impossible possible
What makes you most happy at work?
challenges possibly meet every day opportunity to provide scientific suggestions and strategies which will make significant impact on the pipeline and company growth
Other Employee Reviews for Karyopharm Therapeutics
×